Huons Global Co., Ltd. (KOSDAQ:084110)
35,500
+850 (2.45%)
Feb 21, 2025, 3:30 PM KST
Huons Global Revenue
Huons Global had revenue of 199.42B KRW in the quarter ending September 30, 2024, with 4.62% growth. This brings the company's revenue in the last twelve months to 811.01B, up 10.88% year-over-year. In the year 2023, Huons Global had annual revenue of 758.38B with 14.15% growth.
Revenue (ttm)
811.01B
Revenue Growth
+10.88%
P/S Ratio
0.54
Revenue / Employee
6.70B
Employees
121
Market Cap
432.39B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 758.38B | 94.01B | 14.15% |
Dec 31, 2022 | 664.36B | 89.72B | 15.61% |
Dec 31, 2021 | 574.65B | 51.60B | 9.87% |
Dec 31, 2020 | 523.05B | 73.62B | 16.38% |
Dec 31, 2019 | 449.42B | 70.74B | 18.68% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
Yuhan | 2,008.84B |
SK Biopharmaceuticals | 511.33B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Hanmi Science | 1,283.65B |
Hanall Biopharma | 134.24B |